DNA Sequencing Market Size, Share, and Trends 2026 to 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on DNA Sequencing Market 

5.1. COVID-19 Landscape: DNA Sequencing Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global DNA Sequencing Market, By Product

8.1. DNA Sequencing Market, by Product

8.1.1. Instruments

8.1.1.1. Market Revenue and Forecast

8.1.2. Consumables

8.1.2.1. Market Revenue and Forecast

8.1.3. Services

Chapter 9. Global DNA Sequencing Market, By Technology

9.1. DNA Sequencing Market, by Technology

9.1.1. Third Generation DNA Sequencing

9.1.1.1. Market Revenue and Forecast

9.1.2. Next-Generation Sequencing

9.1.2.1. Market Revenue and Forecast

9.1.3. Sanger Sequencing

9.1.3.1. Market Revenue and Forecast

Chapter 10. Global DNA Sequencing Market, By Application 

10.1. DNA Sequencing Market, by Application

10.1.1. Clinical Investigation

10.1.1.1. Market Revenue and Forecast

10.1.2. Oncology

10.1.2.1. Market Revenue and Forecast

10.1.3. Forensics & Agrigenomics

10.1.3.1. Market Revenue and Forecast

10.1.4. Reproductive Health

10.1.4.1. Market Revenue and Forecast

10.1.5. HLA Typing

10.1.5.1. Market Revenue and Forecast

10.1.6. Others

10.1.6.1. Market Revenue and Forecast

Chapter 11. Global DNA Sequencing Market, By End-Use 

11.1. DNA Sequencing Market, by End-Use

11.1.1. Clinical Research

11.1.1.1. Market Revenue and Forecast

11.1.2. Academic Research

11.1.2.1. Market Revenue and Forecast

11.1.3. Biotechnology & Pharmaceutical Companies

11.1.3.1. Market Revenue and Forecast

11.1.4. Hospitals & Clinics

11.1.4.1. Market Revenue and Forecast

11.1.5. Others

11.1.5.1. Market Revenue and Forecast

Chapter 12. Global DNA Sequencing Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product

12.1.2. Market Revenue and Forecast, by Technology

12.1.3. Market Revenue and Forecast, by Application

12.1.4. Market Revenue and Forecast, by End-Use

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product

12.1.5.2. Market Revenue and Forecast, by Technology

12.1.5.3. Market Revenue and Forecast, by Application

12.1.5.4. Market Revenue and Forecast, by End-Use

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product

12.1.6.2. Market Revenue and Forecast, by Technology

12.1.6.3. Market Revenue and Forecast, by Application

12.1.6.4. Market Revenue and Forecast, by End-Use

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product

12.2.2. Market Revenue and Forecast, by Technology

12.2.3. Market Revenue and Forecast, by Application

12.2.4. Market Revenue and Forecast, by End-Use

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product

12.2.5.2. Market Revenue and Forecast, by Technology

12.2.5.3. Market Revenue and Forecast, by Application

12.2.5.4. Market Revenue and Forecast, by End-Use

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product

12.2.6.2. Market Revenue and Forecast, by Technology

12.2.6.3. Market Revenue and Forecast, by Application

12.2.6.4. Market Revenue and Forecast, by End-Use

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product

12.2.7.2. Market Revenue and Forecast, by Technology

12.2.7.3. Market Revenue and Forecast, by Application

12.2.7.4. Market Revenue and Forecast, by End-Use

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product

12.2.8.2. Market Revenue and Forecast, by Technology

12.2.8.3. Market Revenue and Forecast, by Application

12.2.8.4. Market Revenue and Forecast, by End-Use

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product

12.3.2. Market Revenue and Forecast, by Technology

12.3.3. Market Revenue and Forecast, by Application

12.3.4. Market Revenue and Forecast, by End-Use

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product

12.3.5.2. Market Revenue and Forecast, by Technology

12.3.5.3. Market Revenue and Forecast, by Application

12.3.5.4. Market Revenue and Forecast, by End-Use

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product

12.3.6.2. Market Revenue and Forecast, by Technology

12.3.6.3. Market Revenue and Forecast, by Application

12.3.6.4. Market Revenue and Forecast, by End-Use

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product

12.3.7.2. Market Revenue and Forecast, by Technology

12.3.7.3. Market Revenue and Forecast, by Application

12.3.7.4. Market Revenue and Forecast, by End-Use

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product

12.3.8.2. Market Revenue and Forecast, by Technology

12.3.8.3. Market Revenue and Forecast, by Application

12.3.8.4. Market Revenue and Forecast, by End-Use

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product

12.4.2. Market Revenue and Forecast, by Technology

12.4.3. Market Revenue and Forecast, by Application

12.4.4. Market Revenue and Forecast, by End-Use

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product

12.4.5.2. Market Revenue and Forecast, by Technology

12.4.5.3. Market Revenue and Forecast, by Application

12.4.5.4. Market Revenue and Forecast, by End-Use

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product

12.4.6.2. Market Revenue and Forecast, by Technology

12.4.6.3. Market Revenue and Forecast, by Application

12.4.6.4. Market Revenue and Forecast, by End-Use

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product

12.4.7.2. Market Revenue and Forecast, by Technology

12.4.7.3. Market Revenue and Forecast, by Application

12.4.7.4. Market Revenue and Forecast, by End-Use

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product

12.4.8.2. Market Revenue and Forecast, by Technology

12.4.8.3. Market Revenue and Forecast, by Application

12.4.8.4. Market Revenue and Forecast, by End-Use

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product

12.5.2. Market Revenue and Forecast, by Technology

12.5.3. Market Revenue and Forecast, by Application

12.5.4. Market Revenue and Forecast, by End-Use

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product

12.5.5.2. Market Revenue and Forecast, by Technology

12.5.5.3. Market Revenue and Forecast, by Application

12.5.5.4. Market Revenue and Forecast, by End-Use

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product

12.5.6.2. Market Revenue and Forecast, by Technology

12.5.6.3. Market Revenue and Forecast, by Application

12.5.6.4. Market Revenue and Forecast, by End-Use

Chapter 13. Company Profiles

13.1. Agilent Technologies

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Illumina, Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. QIAGEN

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Perkin Elmer

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Thermo Fisher Scientific

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Hoffmann-La Roche Ltd.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Macrogen, Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Bio-Rad Laboratories, Inc.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Oxford Nanopore Technologies Ltd.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Myriad Genetics

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms